The Highest Standard in Peptide Research.

Bodytide Wellness Lab
WEIGHT MANAGEMENT & METABOLIC OPTIMISATION // HORMONE OPTIMISATION & VITALITY

TESAMORELIN 30MG

Stubborn belly fat reduction

Tesamorelin is a stabilized 44-amino acid Growth Hormone-Releasing Hormone (GHRH) analogue engineered to target visceral abdominal fat clearance and stimulate natural growth hormone pulses.

TESAMORELIN 30MG
£125.00

Active Ingredient: 30.00mg per pen

Volume: 3.00ml

For in vitro use only.

Typical research suggests 5 clicks daily, weeks 1-2. Then 10 clicks daily thereafter.

All our Peptide Pens are designed to last a minimum of 30 days.

Taxes included. Shipping calculated at checkout.

Expected Benefits

By combining clinical research with day-to-day wellness support, this protocol offers clear metabolic improvements:

Visceral Fat Clearance: Specifically targets and reduces hard, inflammatory abdominal visceral fat stores.
Endogenous GH Stimulation: Stimulates natural, pulsatile growth hormone release from pituitary cells.
Lipid Profile Improvement: Promotes healthy triglycerides and cholesterol balance.
Lean Mass Preservation: Protects structural muscle tissue during active visceral fat loss.
Cognitive & Metabolic Support: Improves metabolic flexibility and executive cognitive processing in aging models.

Manufactured and tested to
pharmaceutical standards

EU GMP ISO 9001 ISO 13485 ISO 14644
To maintain the integrity of your protocol, correct storage is essential. Always store your Peptide pen in its protective casing within the refrigerator, strictly between 2°C and 8°C. Ensure the pen is shielded from direct light and never allowed to freeze. When travelling, we recommend utilizing a temperature-controlled travel case.

What is TESAMORELIN 30MG?

Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) with a trans-3-hexenoyl group attached to its N-terminus. This structural modification extends its plasma half-life, allowing it to stimulate the pituitary gland to release endogenous growth hormone, preferentially mobilizing deep visceral abdominal fat.

The Cellular Mechanism

GHRH Receptor Binding: Binds to GHRH receptors on pituitary somatotrophs to trigger natural, pulsatile growth hormone secretion.
Visceral Lipolysis Activation: Elevated GH activates lipolysis in visceral adipocytes through cyclic AMP (cAMP) messaging pathways.

Protocol Schedule

Clinical evaluation studies show that a typical research protocol ranges from 500mcg to 1mg daily. To allow cellular receptors and renal pathways to adapt comfortably, researchers follow a step-by-step escalation schedule:

Weeks 1-2 (Baseline Priming): An initial daily dose of 500mcg (5 clicks once per day).

Weeks 2 Onwards (Active Titration): The protocol scales to 1mg daily (10 clicks once per day).

Once targets are achieved, dosage can be reviewed and adjusted according to results.

Possible Side Effects

Transient Injection Site Reaction: Mild redness, itching, or swelling at the application site.
Mild Fluid Retention: Temporary, minor fluid retention or joint stiffness in the hands during initial weeks.